Novus Is Building Proprietary Software System to Handle Membership Growth
MIAMI, FL–(Marketwired – Dec 29, 2014) – Novus Acquisition & Development Corp (OTC PINK:NDEV), wholly owned subsidiary Novus Medical Group, Inc., a service provider of the health and wellness savings plan, “Novus MedPlan,” announces that it has retained PR Revolution (https://www.prrevolution.com) to build a proprietary software platform to handle rapid growth.
“Because of our vast response to the Novus MedPlan enrollment, which opened in October, Novus has retained PR Revolution to rebrand the current Novus Medical Group website to help facilitate our growth. The new website will allow patients to be connected to providers in a seamless fashion,” said Frank Labrozzi, Chairman of Novus. “The benefits of our software will allow Novus to continue to meet the needs of our growing Provider and Patient network and we anticipate the completion of the software in January.” In addition, the Company is moving forward with the filing of the Form 10 with SEC to be recognized as a fully reporting OTCQB company in January 2015.
“We are excited to have been awarded the development project for Novus MedPlan. This is an exciting project for our entire team and we are looking forward to the final product,” said Adam Segall, President of PR Revolution.
Novus Acquisition & Development Corp. (“Novus”) provides health insurance and related insurance solutions to the medical marijuana industry in states where legal programs exist. The Company also plans to offer physicians’ education programs, pharmaceutical R&D, compliance, and business development services within the industry.
NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional.
The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government’s enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.
About PR Revolution
PR Revolution is a full-service public relations and digital marketing agency, with offices in New York City and Livingston, New Jersey. The firm’s seasoned and diverse team offers clients extensive expertise across multiple sectors including cannabis, insurance, fashion and beauty, media and entertainment, food and beverage, travel and hospitality as well as technology. Visithttps://www.prrevolution.com for more information.
This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Main Tel: (855) 422-4463
Email: Email Contact
Novus Acquisition & Development Corp
Gary F. Labrozzi
Website: www.ndev.biz or www.novusmedicalgroup.com
Email: Email Contact
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | firstname.lastname@example.org